| Bid Price | 64.20p | High Price | 64.40p |
|---|
| Ask Price | 64.30p | Low Price | 64.20p |
|---|
| Open Price | 64.30p | Spread | 0.16% |
|---|
| Prev Close | 64.20p | Volume | 545,178 |
|---|
Alliance Pharma PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 17, 2025 | 64.30 | 64.40 | 64.20 | 64.20 | 545,178 |
| Apr 16, 2025 | 64.30 | 64.30 | 64.20 | 64.20 | 235,584 |
| Apr 15, 2025 | 64.30 | 64.30 | 64.20 | 64.20 | 192,236 |
| Apr 14, 2025 | 64.30 | 64.30 | 64.20 | 64.20 | 123,498 |
Alliance Pharma PLC Information
| Name | Alliance Pharma PLC | Index | FTSE AIM 100 |
|---|
| ISIN | GB0031030819 | Epic | APH |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | AMSM |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Closed |
|---|
| Shares in Issue | 540.57 m | Prev Close | 64.20p |
|---|
| PE Ratio | 285.714286 | Market Cap | £347.04 m |
|---|
| Div Yield | 0 | Div per Share | £0.00 |
|---|
| EPS | -£0.03 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.039218 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.843422 | Quick Ratio | 2.144886 |
|---|
Alliance Pharma PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 16/10/23 | EXR | Peter Butterfield | RES | 98,342 @ £0.00 | £0.00 |
| 16/10/23 | SELL | Peter Butterfield | RES | 74,343 @ £0.39 | £29,006.00 |
| 16/10/23 | EXR | Andrew Franklin | ED | 55,592 @ £0.00 | £0.00 |
| 16/10/23 | SELL | Andrew Franklin | ED | 42,053 @ £0.39 | £16,407.00 |
| 20/07/23 | BUY | Joanna Le Couilliard | RES | 40,957 @ £0.49 | £19,987.00 |
| 19/07/23 | BUY | Andrew Franklin | ED | 50,988 @ £0.49 | £25,010.00 |
| 19/07/23 | BUY | Richard Jones | NED | 53,000 @ £0.47 | £24,963.00 |
| 22/11/21 | SEXR | Peter Butterfield | RES | 269,417 @ £1.02 | £276,152.00 |
| 22/11/21 | EXR | Peter Butterfield | RES | 269,417 @ £0.48 | £127,973.00 |
| 22/04/21 | EXR | Peter Butterfield | RES | 205,000 @ £0.53 | £108,650.00 |
Alliance Pharma PLC News
